The Role of the High-Sensitivity C-Reactive Protein in Patients with Stable Non-Cystic Fibrosis Bronchiectasis
Pulmonary Medicine · 2013 · 2013 · 1-8
DOI: 10.1155/2013/795140 ↗Abstract
Study Objectives. The aim of this study is to investigate the correlation between serum high-sensitivity C-reactive protein (hs-CRP) and other clinical tools including high-resolution computed tomography (HRCT) in patients with stable non-CF bronchiectasis. Design. A within-subject correlational study of a group of patients with stable non-CF bronchiectasis, who were recruited from our outpatient clinic, was done over a two-year period. Measurements. Sixty-nine stable non-CF bronchiectasis patients were evaluated in terms of hs-CRP, 6-minute walk test, pulmonary function tests, and HRCT. Results. Circulating hs-CRP levels were significantly correlated with HRCT scores ( n = 69 , r = 0.473 , P < 0 . 001 ) and resting oxygenation saturation ( r = - 0.269 , P = 0.025 ). HRCT severity scores significantly increased in patients with hs-CRP level of 4.26 mg/L or higher (mean ± SD 28.1 ± 13.1 ) compared to those with hs-CRP level less than 4.26 mg/L ( 31.7 ± 9.8 , P = 0.004 ). Oxygenation saturation at rest was lower in those with hs-CRP level of 4.26 mg/L or higher ( 93.5 ± 4.4 % ) compared to those with hs-CRP level less than 4.26 mg/L ( 96.4 ± 1.6 % , P = 0.001 ). Conclusion. There was a good correlation between serum hs-CRP and HRCT scores in the patients with stable non-CF bronchiectasis.
EUVIMED